142 related articles for article (PubMed ID: 9158509)
1. The clinical and histological features of transitional cell carcinoma of the bladder with microcysts: analysis of 12 cases.
Paz A; Rath-Wolfson L; Lask D; Koren R; Manes A; Mukamel E; Gal R
Br J Urol; 1997 May; 79(5):722-5. PubMed ID: 9158509
[TBL] [Abstract][Full Text] [Related]
2. The significance of tumour grade in predicting disease progression in stage Ta transitional cell carcinoma of the urinary bladder.
Chen SS; Chen KK; Lin AT; Chang YH; Wu HH; Hsu TH; Chang LS
Br J Urol; 1996 Aug; 78(2):209-12. PubMed ID: 8813915
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for positive findings in patients with high-grade T1 bladder cancer treated with transurethral resection of bladder tumour (TUR) and bacille Calmette-Guérin therapy and the decision for a repeat TUR.
Orsola A; Cecchini L; Raventós CX; Trilla E; Planas J; Landolfi S; de Torres I; Morote J
BJU Int; 2010 Jan; 105(2):202-7. PubMed ID: 19558557
[TBL] [Abstract][Full Text] [Related]
4. Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma.
Amin MB; Ro JY; el-Sharkawy T; Lee KM; Troncoso P; Silva EG; Ordóñez NG; Ayala AG
Am J Surg Pathol; 1994 Dec; 18(12):1224-32. PubMed ID: 7977945
[TBL] [Abstract][Full Text] [Related]
5. Conservative treatment of superficial transitional cell carcinoma of prostatic urethra with intravesical BCG.
Orihuela E; Herr HW; Whitmore WF
Urology; 1989 Nov; 34(5):231-7. PubMed ID: 2815442
[TBL] [Abstract][Full Text] [Related]
6. Urothelial tumours of the urinary bladder: a histopathological study of cystoscopic biopsies.
Vaidya S; Lakhey M; K C S; Hirachand S
JNMA J Nepal Med Assoc; 2013; 52(191):475-8. PubMed ID: 24907954
[TBL] [Abstract][Full Text] [Related]
7. [Role of BCG in T1G3 bladder transitional cell carcinoma (TCC): our experience].
Comeri GC; Belvisi P; Conti G; Cretarola E; Duvia R; Furgoni R; Gianneo E; Radice GP
Arch Ital Urol Androl; 1996 Feb; 68(1):55-9. PubMed ID: 8664924
[TBL] [Abstract][Full Text] [Related]
8. Management of high-risk non-muscle invasive bladder cancer.
Brausi M; Olaru V
Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
[TBL] [Abstract][Full Text] [Related]
9. Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder.
Elsamman E; Fukumori T; Kasai T; Nakatsuji H; Nishitani MA; Toida K; Ali N; Kanayama HO
BJU Int; 2006 Jun; 97(6):1202-7. PubMed ID: 16686711
[TBL] [Abstract][Full Text] [Related]
10. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Raman JD; Sosa RE; Vaughan ED; Scherr DS
Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
[TBL] [Abstract][Full Text] [Related]
11. The management of T1G3 bladder cancer.
Bogdanović J; Marusić G; Djozić J; Sekulić V; Budakov P; Dejanović N; Stojkov J
Urol Int; 2002; 69(4):263-5. PubMed ID: 12444280
[TBL] [Abstract][Full Text] [Related]
12. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
[TBL] [Abstract][Full Text] [Related]
13. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
[TBL] [Abstract][Full Text] [Related]
14. 15-year experience on intravesical therapy of T1G3 urinary bladder cancer: a conservative approach.
Cheng CW; Chan SF; Chan LW; Chan CK; Ng CF; Cheung HY; Chan SY; Wong WS; Lai FM; Li ML
Jpn J Clin Oncol; 2004 Apr; 34(4):202-5. PubMed ID: 15121756
[TBL] [Abstract][Full Text] [Related]
15. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
Chou EC; Lin AT; Chen KK; Chang LS
Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
[TBL] [Abstract][Full Text] [Related]
16. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
[TBL] [Abstract][Full Text] [Related]
17. Bladder tumors invading the lamina propria (stage T1): influence of endovesical BCG therapy on recurrence and progression.
Boccon-Gibod L; Leleu C; Herve JM; Belas M; Steg A
Prog Clin Biol Res; 1989; 310():161-9. PubMed ID: 2771991
[TBL] [Abstract][Full Text] [Related]
18. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance.
Shen SS; Lerner SP; Muezzinoglu B; Truong LD; Amiel G; Wheeler TM
Hum Pathol; 2006 Jun; 37(6):726-34. PubMed ID: 16733214
[TBL] [Abstract][Full Text] [Related]
19. [Preservation of the bladder in transitional cell tumors infiltrating the lamina propria].
Benoît G; Alexandre L; Bensadoun H; Vieillefond A; Martin PR; Martin A; Jardin A
Presse Med; 1991 Sep; 20(30):1425-8. PubMed ID: 1835025
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal high-polysomies predict tumour progression in T1 transitional cell carcinoma of the bladder.
Ribal MJ; Alcaraz A; Mengual L; Carrio A; Lopez-Guillermo A; Mallofré C; Palou J; Gelabert A; Villavicencio H
Eur Urol; 2004 May; 45(5):593-9. PubMed ID: 15082201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]